Depression News and Research

Latest Depression News and Research

Asthma medication linked with neuropsychiatric symptoms

In a Pharmacology Research & Perspectives study, the asthma medication montelukast (trade name Singulair) was linked with neuropsychiatric reactions such as depression and aggression, with nightmares being especially frequent in children.

18 Sep 2017

Reducing mental health disparities through online therapy

For many years, I was a psychologist at a very large US university mental health center and we constantly had more people seeking help than we could possibly accommodate. That is a ubiquitous problem across lots of sectors, including community mental health and private practice in any rural area.

18 Sep 2017

Research provides insight into how imbalance in neural precursor cells may contribute to brain diseases

Salk Institute scientists have discovered that an interaction between two key proteins helps regulate and maintain the cells that produce neurons.

15 Sep 2017

Funding cuts damaging young people's access to mental health services, say researchers

Funding cuts and austerity measures are damaging young people's access to mental health services, with potentially long-term consequences for their mental wellbeing, say researchers at the University of Cambridge.

15 Sep 2017

Research finds postpartum depressive symptoms in 45% of parents when newborns leave NICU

Almost half of parents whose children were admitted to Children's National Health System's neonatal intensive care unit experienced postpartum depressive symptoms, anxiety, and stress when their newborns were discharged from the hospital.

15 Sep 2017

Study suggests magnesium cream could be used to combat deficiencies

A new study by the University of Hertfordshire has revealed that a magnesium cream could be used as an alternative to tablets to combat major health problems including high blood pressure which are linked with deficiency.

From BetterYou Ltd 15 Sep 2017

Study examines effectiveness of placebo and antidepressants in children, adolescents

Although the clinical efficacy of antidepressants in children and adolescents is proven, it is frequently accompanied by side effects. In addition, the influence of the placebo effect on the efficacy of antidepressants is unclear.

15 Sep 2017

New analysis sheds light on struggles faced by carers in the UK

A new analysis taken from a global survey of 3,086 carers has cast new light on the struggles carers in the UK face today. The analysis reveals the majority of caregivers in the UK are relatively new to caring, with most taking care of someone for five years or less, furthermore, the data reveals 34% are millennials (between the ages of 18 – 34).

15 Sep 2017

FDA permits first digital therapeutic device for treatment of substance use disorders

The United States Food and Drug Administration (US FDA) yesterday – 14th of September 2017, permitted the marketing of an application developed for mobiles that would help in the treatment of substance use disorders (SUD).

14 Sep 2017

Antidepressant users have higher risk of death than non-users, researchers find

Antidepressant medications, most commonly prescribed to reduce depression and anxiety, increase the risk of death, according to new findings by a McMaster-led team of researchers.

14 Sep 2017

Research shows how sportspeople struggle to adjust to life after retirement

New research shows how top-level sportspeople can struggle to adjust to life after retirement, with their identities continuing to be defined by their former careers.

14 Sep 2017

Delaying minor surgery for pediatric patients may not offer any neurodevelopmental benefit

Children under age 5 who underwent minor surgery requiring anesthesia had a 26 percent increased risk of later diagnosis with a mental disorder. However, the timing of the procedure did not affect this risk, according to a new study at Columbia University's Mailman School of Public Health and College of Physicians and Surgeons.

14 Sep 2017

New HIVMA guidelines recommend screening everyone with HIV for chronic pain

Because ongoing pain is a significant problem that affects 39 to 85 percent of people living with HIV, everyone with the infection should be assessed for chronic pain, recommend guidelines released by the HIV Medicine Association of the Infectious Diseases Society of America and published in the journal Clinical Infectious Diseases.

14 Sep 2017